Israel Active

I reported previously on Israel’s Eximo and its lasers for treating peripheral artery disease (PAD). The Center for Cardiovascular Excellence in Orlando, Florida is the first to use Eximo’s B-Laser Atherectomy System commercially to successfully treat a patient.

Tel Aviv’s Sourasky (Ichilov) Hospital and Israel’s largest health companies Clalit and Maccabi will use the algorithms of Israel’s Zebra Medical Vision to analyze scanned images from X-rays, CT scans and MRIs.

I reported previously on Israel’s Omeq Medical and its smart sensor-based epidural injection system.  Omeq has partnered with Shanghai-based Pharos Medical, which will establish a production line and commercialize Omeq’s system in China.

Researchers from Israel’s Technion Institute have devised a system for measuring the effectiveness of a combination of antibiotics in fighting infection.

Philadelphia's Thomas Jefferson University has partnered with the Israel Innovation Authority (IIA) to form the Jefferson-Israel Center. The US university will provide a $1 million fund for Israeli companies to advance healthcare technology solutions. They can also access Jefferson's medical facilities.

The Save the Children Fund (like Oxfam and UNICEF) is no friend to Israel.  However, it didn’t stop the NGO from buying monitoring systems from Israel’s EarlySense to continuously track key vital signs of newborns in hospitals in Nairobi, Kenya.  Another BDS fail.

Microsoft’s Israeli R&D team, supported by several US medical partners, have launched the Microsoft Healthcare Bot. This innovative AI-powered virtual health assistant service aims to empower healthcare organizations to build and deploy virtual health assistants.

The Pre-Implantation Genetic Unit of Jerusalem’s Shaare Zedek Medical Center uses the latest technology to ensure IVF patients have healthy babies. All procedures are in accordance with Jewish law and religious authorities are consulted when necessary.

I reported previously on Xvision (previously VIZOR),  the Augmented Reality surgical navigation system from Israel’s Augmedics. Following testing on cadavers, Xvision is now undergoing human trials and has been successfully tested in six spinal operations.

Doctors in Kazakhstan have implanted a wireless ventricular assist device (VAD) into a human for the first time.  The VAD is made by Jarvik Heart Inc but the technology for charging the battery was developed by Israel-based Leviticus Cardio. Wireless VADs have less risk of infection than wired VADs.